3kdm
From Proteopedia
(Difference between revisions)
m (Protected "3kdm" [edit=sysop:move=sysop]) |
|||
| Line 11: | Line 11: | ||
===Crystal Structure of Human Anti-steroid Fab 5F2 in Complex with Testosterone=== | ===Crystal Structure of Human Anti-steroid Fab 5F2 in Complex with Testosterone=== | ||
| + | |||
| + | <!-- | ||
| + | The line below this paragraph, {{ABSTRACT_PUBMED_21360611}}, adds the Publication Abstract to the page | ||
| + | (as it appears on PubMed at http://www.pubmed.gov), where 21360611 is the PubMed ID number. | ||
| + | --> | ||
| + | {{ABSTRACT_PUBMED_21360611}} | ||
==About this Structure== | ==About this Structure== | ||
[[3kdm]] is a 4 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3KDM OCA]. | [[3kdm]] is a 4 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3KDM OCA]. | ||
| + | |||
| + | ==Reference== | ||
| + | <ref group="xtra">PMID:021360611</ref><references group="xtra"/> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Niemi, M H.]] | [[Category: Niemi, M H.]] | ||
[[Category: Rouvinen, J.]] | [[Category: Rouvinen, J.]] | ||
| + | [[Category: Anti-steroid]] | ||
| + | [[Category: Antibody]] | ||
| + | [[Category: Immune system]] | ||
| + | [[Category: Immunoglobulin fab fragment]] | ||
Revision as of 07:16, 7 December 2011
Crystal Structure of Human Anti-steroid Fab 5F2 in Complex with Testosterone
Template:ABSTRACT PUBMED 21360611
About this Structure
3kdm is a 4 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Niemi MH, Takkinen K, Amundsen LK, Soderlund H, Rouvinen J, Hoyhtya M. The testosterone binding mechanism of an antibody derived from a naive human scFv library. J Mol Recognit. 2011 Mar-Apr;24(2):209-19. doi: 10.1002/jmr.1039. PMID:21360611 doi:10.1002/jmr.1039
